XBI is an equal-weighted ETF that follows the S&P Biotechnology Select Industry Index. 47 million over the past three months. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 97. S. 5. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. 97. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. View the XBI funds market news. XBI is an almost pure play on the biotechnology sector. Some of the top XBI holdings continue to defy the bear market. 01%). 78% in the last one year. 90 in this past 52. If Moderna's share price. The fund has a beta of 0. 76% allocation. The weighted harmonic average of closing market price divided by. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). In addition to holding 155 positions, its top 10. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. argenx SE ADR. View complete XBI exchange traded fund holdings for better informed ETF trading. XBI focuses on a narrow sector of the health care sector, and as such is probably too precise for most investors. DLTR. 35% ; Sectors:. SPDR S&P Biotech ETF ETF holdings by MarketWatch. This major support zone runs from $101. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . View complete IBB exchange traded fund holdings for. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. Holdings; Performance; Risk; Performance Overview-12. 15 billion assets under management. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. 88%. $0. 99%. $6. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 9%: Israel: 3. As illustrated more by the next two charts, comparing the top 10 holdings XBI and IBB. 10 as of November 2, 2022. Taking a look at the XBI, it peaked at $174. 97. The iShares Biotechnology ETF seeks to track the investment results of an index composed of U. 38%. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. 1% over the past year to close the last trading session at $81. 2B. $7. NEW: Experience our best charts yet. 9. S. 81 and $134. VHT has a lower expense ratio than XBI (0. 46% YTD Daily Total Return ETF Summary. 00%) Most Recent Dividend 0. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. 66738-1. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. XBI is a modified equal weighted ETF with about 157 holdings, though that number may change due to issues such as being acquired, among others. XBI comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. XLY News. 03 per $1,000 of principal). S. 76% allocation. Net expense ratio. IMVT. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. According to data from U. Seeking AlphaXBI vs. 47% vs -5. Further, the fund owns $6. Looking at the chart above, XBI's low point in its 52 week range is $62. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. TipRanks | Stock Market Research, News and Analyst Forecasts. 78% of XBI's total assets under management. Fund size is a good indication of how many other investors trust this fund. The ETF has lost about -22. The XBI broke out in Q3 2016 and again in June 2017. The famed investor's Berkshire Hathaway (. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. View complete WCLD exchange traded fund holdings for better informed ETF trading. Minafi categorizes both of these funds as large funds. 2. Published. 84. XBI's top 10 holdings account for about 11. ETF Strategies. Plus view geographic exposure, currency. Nov 20, 2023Top 10 Holdings. ( AMGN) = 9. 7% of assets. 10(-0. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. The top XBI holdings:Glossary: ActiveShareis a measure of the percentage of stock holdings in a manager's portfolio that differ from the benchmark index. 9% vs -5. 79 as the 52 week high point — that compares with a last trade of $133. Looking at the chart above, XBI's low point in its 52 week range is $61. 79 as the 52 week high point — that compares with a last trade of $126. London. It's trading down (17%) versus LABU, down (68%) in one-year performance. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 02%. More XBI Holdings Current Portfolio Date Nov 16, 2023; Equity Holdings 132; Bond Holdings 0;During the previous two years, 872 institutional investors and hedge funds held shares of SPDR S&P Biotech ETF. 01 to $0. N/A. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. XBI has traded between $73. News & World Report, XBI. XBI vs BBH. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. Advertisement. Veeva Systems. WIX. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. 08%. XBI has an overall POWR Rating of D, equating to a Sell. 86 Prior Close 70. Both IBB and XBI are ETFs. ETFs Holding XBI. The fund’s NAV was $81. Holdings. Below is the comparison between BBC and XBI. It can be found in the fund’s most recent prospectus. 15 billion assets under management. There is no guarantee the funds will achieve their stated investment objectives. XBI vs ARKG. 35 %LABU: S&P Biotech Bull 3X Shares ETF:Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron . XBI Price: 68. Twin City Holdings Ltd. Latest SPDR® S&P Biotech ETF (XBI:PCQ:USD) share price with interactive charts, historical prices, comparative analysis, forecasts,. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. It is gross of any fee waivers or expense reimbursements. We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. Themes & Subsectors ETFs. Staples:. 77. 67. There are 10 biotech ETFs that trade in the United States,. The beaten-down prices offer a solid buying opportunity for investors. Dividend Yield. Meanwhile, XBI equal weights its holdings. 5. Lens & Shutter Holdings Ltd. 06 as the 52 week high point — that compares with a last trade of $109. 75M), Brown Advisory. There is no guarantee the funds will achieve their stated investment objectives. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. Holdings. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. XBI, whose index recently expanded, also owns only a handful of established biotech companies. Please call us for more information - (250). VEEV. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. XBI: Head-To-Head ETF Comparison. Company Change % Net. In addition to holding 155 positions, its top 10 holdings make up just 14. Search tickers or categories. It has a total of 153 holdings. 91 (11/14/23) 1 Day XBI 0. $0. In trading on Monday the SPDR S&P Biotech ETF is outperforming other ETFs up about 2% on the day. 16bn USD. Find the latest iShares Biotechnology ETF (IBB) stock quote, history, news and other vital information to help you with your stock trading and investing. 8 million shares. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 06 as the 52 week high point — that compares with a last trade of $102. 79 as the 52 week high point — that compares with a last trade of $133. Dollar Tree Inc. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). Below is the comparison between LABU and XBI. 9. 2, 2023. LABU. 79 in February 2021 and has fallen over (50%) to $76. 96%, and is down about -5. Looking at the chart above, XBI's low point in its 52 week range is $62. 06 a share on Wednesday which marked its lowest level dating back to June 30 of 2022. DLTR. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. 93% of its total assets under management. Export data to Excel for your own analysis. VHT has a higher 5-year return than XBI (7. Sector ETFs. 1% vs 0. Comparing the most. Share your ideas and get valuable insights from the community of like minded traders and investorsAlaunos Therapeutics, Inc. 52%. Both VHT and XBI are ETFs. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. Currency in USD Follow 2W 10W 9M 72. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. 98 and standard deviation of 40. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). The vast majority of XBI holdings have less. High volatility: Small and mid-cap biotech stocks typically exhibit greater price fluctuations, exposing investors to higher levels of market risk and. Holdings. 2% weight, and there are 133 holdings in total in the fund (Figure 1). Compare ETFs IBB and XBI on performance, AUM, flows, holdings, costs and ESG ratings. SPDR S&P Biotech ETF Stock Up 1. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. XBI Holdings5 Beaten-Down ETFs to Buy Now. N/A. 0. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Additionally. 71. Shares of Amgen , IBB's top holding with a weight of 8. February 15, 2023 — 10:47 am EST. Meanwhile, XBI equal weights its holdings. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. IBB has a higher 5-year return than XBI (0. Trades. Performance and Risk So far this year, XBI has added roughly 1. Below is the comparison between ARKG and XBI. Holdings; Performance; Risk; Advertisement. The most heavily invested institutionals were Morgan Stanley ($614. 94 as the 52 week high point — that compares with a last trade of $116. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. Top Holdings . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. Trader's Guide 2024 Ships December 21st. The. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. ETFs are subject to market fluctuation and the risks of their underlying investments. 10 as of November 2, 2022. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Rated on Jun 30, 2023 Published on Jun 30. Free ratings, analyses, holdings, benchmarks, quotes, and news. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 01%). 01 to $0. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. Again, top 10 holdings. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. SPDR® S&P Biotech ETF XBI. The fund’s NAV was $81. IBB vs. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Net Expense Ratio. Last Price Today's Change Today's Volume : Prospectus. 28% so far this year and in the past one. XBI, MDGL, ARWR, CYTK: Large Inflows Detected at ETF. Currency in USD Follow 2W 10W 9M 73. 12 and $91. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. 44 per share, with $92. The Direxion Daily Cloud Computing Bull 2X Shares seek daily investment results, before fees and expenses, of 200% of the performance of the Indxx USA Cloud Computing Index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. ETFs are subject to market fluctuation and the risks of their underlying investments. 0. 89%. Its fund flows were negative $259. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. 2. XBI has a lower 5-year return than XLV (-5. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. Below is the comparison between XBI and XLV. The Composition of the XBI is the Key. Stock Analysis Chart Headlines Holdings Ownership Ratings. 2014. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. 12%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. 15 per share, with $174. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. 45% and is down about -9. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. The fund's investments total to approximately $6. Better trading starts here. Written by BNK Invest for BNK Invest ->. In addition to holding 155 positions, its top 10 holdings make up just 14. The big biotech. 78% so far this year and in the past one year (as of 11/20/2023), respectively. 35%. 06 and standard deviation of 38. 49% weight in the XBI, are bumping into the $164 head resistance and are. Holdings. Performance and Risk. As of 09/30/2023. com. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. AU. 47%. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 85. Both FBT and XBI are ETFs. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). Market On Millstream The. Year-to-date, the SPDR S&P Biotech ETF has lost about -15. 06 as the 52 week high point — that compares with a last trade of $109. Summary. Performance and Risk. large-cap stocks. 33% from the latest price. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. ETF. 2 %. 60 as the 52 week high point — that compares with a last trade of $69. That's the main advantage to investing. **Close price adjusted for splits and dividend and/or capital gain distributions. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Rated on Jun 30, 2023 Published on Jun 30. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. ETFs - IBB, PBE, XBI. 58%: Halozyme Therapeutics Inc:XLY News. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. 86% so far this year and is down about -32. Wix. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. ETF Report Card. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Seeks to track a modified. The latter proposal about IBB determines its main difference from XBI - the former is more focused on the large biotech companies (the share of Amgen Inc. The iShares Core S&P 500 ETF Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of U. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. In trading on Thursday the Uranium ETF is outperforming other ETFs up about 3. 12% in the last one year (as of 03/16/2023). 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. 42 billion worth of net assets. 2. Start Free Trial. 15 billion. Looking at the chart above, XBI's low point in its 52 week range is $68. Holding Companies. Market Capitalization. Total net assets. Thu, Nov 9, 1:16 PM ET, Market News Video. 12% over the last 12 months (as of 07/18/2023). Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. Holdings Details. 2. Fidelity does not endorse or adopt their content. BlackRock Files for Spot Ethereum ETF. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. Looking at the chart above, XBI's low point in its 52 week range is $72. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. View complete XLP exchange traded fund holdings for better informed ETF trading. ETFs are subject to market fluctuation and the risks of their underlying investments. underlying holdings of the fund. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. As of 9/30/23. AMGN. XBI has a Diversified Portfolio. 191), IBB is significantly more concentrated in its top ten holdings than XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 86% so far this year and is down about -32. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. 96% vs -5. 16bn USD. ETF Summary. While IBB has many more holdings than XBI (376 vs. 56, which is an increase of 43. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. 2.